Gossamer Bio, Inc. - Common Stock (NQ:GOSS)

9.450 -0.930 (-8.96%)

Delayed Quote Updated: 4:00 PM EST, Nov 2, 2026 Add to My Watchlist

Price and Volume

Volume	190,788
Open	10.30
Bid (Size)	9.300 (100)
Ask (Size)	9.450 (200)
Prev. Close	10.38
Today's Range	9.300 - 10.35
52wk Range	8.290 - 309.60
Shares Outstanding	75,993,532
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Curious about the stocks that are showing activity after the closing bell on Friday? ↗

September 25, 2026

Via Chartmill

Gossamer Bio Submits New Drug Application to U.S. FDA for Seralutinib for the Treatment of Pulmonary Arterial Hypertension

September 23, 2026

From Gossamer Bio, Inc.

Via Business Wire

Performance

52-Week Range 96.9% below 52-week high

9.450

8.2952W Low 309.6052W High

1 Week 14.7% below 1-week high

9.101W Low 11.081W High

Gossamer Bio, Inc. - Common Stock (GOSS) traded between $8.29 and $309.60 over the past 52 weeks and last traded at $9.45, 96.9% below its 52-week high. Over the past week it ranged between $9.10 and $11.08.

Past 12 Months

-3.3%

-11.3%

-32.0%

-66.3%

-95.9%

-95.1%

1W -$0.32

1M -$1.20

3M -$4.44

6M -$18.58

YTD -$220.95

1Y -$181.75

GOSS was -95.1% over the past year, -66.3% over six months, -95.9% year to date, -3.3% in the last week.

12 Months vs Market

GOSS

-95.1%

DIA

+9.7%

SPY

+10.1%

QQQ

+7.8%

IWM

+13.7%

Over the past 12 months GOSS returned -95.1% versus DIA (Dow) +9.7%, SPY (S&P 500) +10.1%, QQQ (Nasdaq 100) +7.8% and IWM (Russell 2000) +13.7%.

Volume & Liquidity 0.74× 3-mo avg

Today 190,788 3-mo avg 258.1K

160.5K

224.9K

258.1K

285.3K

YTD

238.5K

206.9K

GOSS most recently traded 190,788 shares against a 3-month average daily volume of 258.1K.

More News

Gossamer Bio Appoints Greg Ciongoli to Board of Directors

September 16, 2026

From Gossamer Bio, Inc.

Via Business Wire

Gossamer Bio Announces Effectiveness of 1-for-80 Reverse Stock Split

September 11, 2026

From Gossamer Bio, Inc.

Via Business Wire

Gossamer Bio Announces 1-for-80 Reverse Stock Split

September 09, 2026

From Gossamer Bio, Inc.

Via Business Wire

Gossamer Bio to Present at Cantor Global Healthcare Conference

September 04, 2026

From Gossamer Bio, Inc.

Via Business Wire

Friday's session: most active stocks ↗

August 21, 2026

Via Chartmill

Which stocks are moving before the opening bell on Friday? ↗

August 21, 2026

Via Chartmill

Gossamer Bio Announces Up to $250 Million Structured Private Placement, Including $150 Million of Committed Capital, to Fund Seralutinib Through Potential FDA Approval

August 21, 2026

From Gossamer Bio, Inc.

Via Business Wire

Curious about the stocks that are showing activity after the closing bell on Friday? ↗

August 14, 2026

Via Chartmill

Gossamer Bio Announces Second Quarter 2026 Financial Results and Provides Business Update

August 13, 2026

From Gossamer Bio, Inc.

Via Business Wire

Check out the stocks that are attracting the most attention and driving market activity. ↗

July 28, 2026

Via Chartmill

Undervalued Stocks in Focus: IGC, CISS, TOON, GOSS, KIDZ Enter Catalyst-Rich Growth Phase

July 28, 2026

Via AB Newswire

Which stocks are moving before the opening bell on Tuesday? ↗

July 28, 2026

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 28, 2026

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 27, 2026

Via Benzinga

Top movers in Monday's after hours session ↗

July 27, 2026

Via Chartmill

Which stocks are moving on Monday? ↗

July 27, 2026

Via Chartmill

Curious about the most active stocks on Monday? ↗

July 27, 2026

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

July 27, 2026

Via Benzinga

Monday's session: top gainers and losers ↗

July 27, 2026

Via Chartmill

These stocks that are showing activity before the opening bell on Monday. ↗

July 27, 2026

Via Chartmill

Gossamer Bio Announces FDA Regulatory Update and Reacquisition of Worldwide Rights Related to Seralutinib and Provides a Business Update

July 27, 2026

From Gossamer Bio, Inc.

Via Business Wire

Top movers in Monday's after hours session ↗

July 20, 2026

Via Chartmill

Gossamer Bio, Inc. Announces Determination of Conversion Rate for 7.50% Convertible Senior Secured First Lien Notes due 2030 and Exercise Price for Purchase Warrants

July 01, 2026

From Gossamer Bio, Inc.

Via Business Wire

Frequently Asked Questions

Is Gossamer Bio, Inc. - Common Stock publicly traded?

Yes, Gossamer Bio, Inc. - Common Stock is publicly traded.

What exchange does Gossamer Bio, Inc. - Common Stock trade on?

Gossamer Bio, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Gossamer Bio, Inc. - Common Stock?

The ticker symbol for Gossamer Bio, Inc. - Common Stock is GOSS on the Nasdaq Stock Market

What is the current price of Gossamer Bio, Inc. - Common Stock?

The current price of Gossamer Bio, Inc. - Common Stock is 9.450

When was Gossamer Bio, Inc. - Common Stock last traded?

The last trade of Gossamer Bio, Inc. - Common Stock was at 11/02/26 04:00 PM ET

What is the market capitalization of Gossamer Bio, Inc. - Common Stock?

The market capitalization of Gossamer Bio, Inc. - Common Stock is 718.14M

How many shares of Gossamer Bio, Inc. - Common Stock are outstanding?

Gossamer Bio, Inc. - Common Stock has 718M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.